Hanako Furukori

1.4k total citations
53 papers, 1.0k citations indexed

About

Hanako Furukori is a scholar working on Psychiatry and Mental health, Pediatrics, Perinatology and Child Health and Pharmacology. According to data from OpenAlex, Hanako Furukori has authored 53 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 44 papers in Psychiatry and Mental health, 10 papers in Pediatrics, Perinatology and Child Health and 8 papers in Pharmacology. Recurrent topics in Hanako Furukori's work include Schizophrenia research and treatment (41 papers), Bipolar Disorder and Treatment (22 papers) and Pharmacological Effects and Toxicity Studies (9 papers). Hanako Furukori is often cited by papers focused on Schizophrenia research and treatment (41 papers), Bipolar Disorder and Treatment (22 papers) and Pharmacological Effects and Toxicity Studies (9 papers). Hanako Furukori collaborates with scholars based in Japan, Belgium and Russia. Hanako Furukori's co-authors include Sunao Kaneko, Norio Yasui‐Furukori, Norio Sugawara, Taku Nakagami, Manabu Saito, Tsuyoshi Kondo, Yasushi Sato, Akihito Suzuki, Norio Yasui‐Furukori and Akira Fujii and has published in prestigious journals such as PLoS ONE, Neuropsychopharmacology and Journal of Affective Disorders.

In The Last Decade

Hanako Furukori

53 papers receiving 1.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Hanako Furukori Japan 20 542 250 150 136 118 53 1.0k
Taku Nakagami Japan 19 454 0.8× 177 0.7× 158 1.1× 156 1.1× 107 0.9× 50 941
Margaret T. Susce United States 18 557 1.0× 450 1.8× 114 0.8× 198 1.5× 256 2.2× 19 1.2k
Kelly L. Cozza United States 17 370 0.7× 368 1.5× 45 0.3× 236 1.7× 122 1.0× 52 1.2k
Roland Berecz Hungary 19 381 0.7× 409 1.6× 58 0.4× 114 0.8× 73 0.6× 38 1.0k
Maria I. Van Rompay United States 13 285 0.5× 113 0.5× 69 0.5× 80 0.6× 145 1.2× 21 1.9k
Takuro Sugai Japan 19 386 0.7× 96 0.4× 133 0.9× 82 0.6× 139 1.2× 63 862
Margaret A. Kirshner United States 26 946 1.7× 188 0.8× 51 0.3× 185 1.4× 120 1.0× 40 2.1k
Roos van Westrhenen Netherlands 15 270 0.5× 236 0.9× 41 0.3× 119 0.9× 78 0.7× 40 1.1k
Timi Edeki United States 19 336 0.6× 394 1.6× 99 0.7× 184 1.4× 225 1.9× 41 1.6k
Pietro Gareri Italy 31 844 1.6× 67 0.3× 192 1.3× 170 1.3× 220 1.9× 103 2.3k

Countries citing papers authored by Hanako Furukori

Since Specialization
Citations

This map shows the geographic impact of Hanako Furukori's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hanako Furukori with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hanako Furukori more than expected).

Fields of papers citing papers by Hanako Furukori

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hanako Furukori. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hanako Furukori. The network helps show where Hanako Furukori may publish in the future.

Co-authorship network of co-authors of Hanako Furukori

This figure shows the co-authorship network connecting the top 25 collaborators of Hanako Furukori. A scholar is included among the top collaborators of Hanako Furukori based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hanako Furukori. Hanako Furukori is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Yasui‐Furukori, Norio, Aoi Sato, Takashi Fukasawa, et al.. (2023). Prescribing Trends for the Same Patients with Schizophrenia Over 20 Years. Neuropsychiatric Disease and Treatment. Volume 19. 921–928. 5 indexed citations
2.
Sugawara, Norio, Aoi Sato, Kensuke Miyazaki, et al.. (2023). Factors associated with the initiation of laxative use in the same patients with schizophrenia over a 20‐year period: Retrospective cohort study. Neuropsychopharmacology Reports. 44(1). 60–66. 1 indexed citations
3.
Sugawara, Norio, Katsuji Suzuki, Akira Fujii, et al.. (2021). Different Attitudes of Patients and Psychiatrists Toward Benzodiazepine Treatment. Neuropsychiatric Disease and Treatment. Volume 17. 1927–1936. 1 indexed citations
4.
Yoshida, Kazutaka, Norio Sugawara, Hanako Furukori, et al.. (2018). Differences in etiological beliefs about schizophrenia among patients, family, and medical staff. Neuropsychiatric Disease and Treatment. Volume 15. 137–142. 7 indexed citations
5.
Sugawara, Norio, Kazuma Danjo, Hanako Furukori, et al.. (2017). Work–family conflict as a mediator between occupational stress and psychological health among mental health nurses in Japan. Neuropsychiatric Disease and Treatment. Volume 13. 779–784. 51 indexed citations
6.
Sugawara, Norio, Norio Yasui‐Furukori, Kazuma Danjo, et al.. (2014). Relationship between occupational stress and depression among psychiatric nurses in Japan. Archives of Environmental & Occupational Health. 71(1). 10–15. 64 indexed citations
7.
Sugawara, Norio, Norio Yasui‐Furukori, Yasushi Sato, et al.. (2013). Body mass index and quality of life among outpatients with schizophrenia in Japan. BMC Psychiatry. 13(1). 22 indexed citations
8.
Yasui‐Furukori, Norio, Norio Sugawara, Shoko Tsuchimine, et al.. (2013). Comparing the influences of age and disease on the Brief Assessment of Cognition in Schizophrenia in Japanese patients with schizophrenia. Neuropsychiatric Disease and Treatment. 9. 1203–1203. 11 indexed citations
9.
Sugawara, Norio, Norio Yasui‐Furukori, Yasushi Sato, et al.. (2011). Comparison of prevalence of metabolic syndrome in hospital and community-based Japanese patients with schizophrenia. Annals of General Psychiatry. 10(1). 21–21. 30 indexed citations
10.
Sugawara, Norio, Norio Yasui‐Furukori, Yasushi Sato, et al.. (2010). Prevalence of metabolic syndrome among patients with schizophrenia in Japan. Schizophrenia Research. 123(2-3). 244–250. 74 indexed citations
11.
Yasui‐Furukori, Norio, Manabu Saito, Taku Nakagami, et al.. (2010). Gender-specific prolactin response to antipsychotic treatments with risperidone and olanzapine and its relationship to drug concentrations in patients with acutely exacerbated schizophrenia. Progress in Neuro-Psychopharmacology and Biological Psychiatry. 34(3). 537–540. 28 indexed citations
12.
Kaneda, Ayako, Norio Yasui‐Furukori, Manabu Saito, et al.. (2010). Characteristics of the tree‐drawing test in chronic schizophrenia. Psychiatry and Clinical Neurosciences. 64(2). 141–148. 17 indexed citations
13.
Kaneda, Ayako, Norio Yasui‐Furukori, Takashi Umeda, et al.. (2010). Comparing the Influences of Age and Disease on Distortion in the Clock Drawing Test in Japanese Patients With Schizophrenia. American Journal of Geriatric Psychiatry. 18(10). 908–916. 4 indexed citations
14.
Yasui‐Furukori, Norio, Hanako Furukori, Manabu Saito, et al.. (2003). Poor Reliability of Therapeutic Drug Monitoring Data for Haloperidol and Bromperidol Using Enzyme Immunoassay. Therapeutic Drug Monitoring. 25(6). 709–714. 2 indexed citations
15.
Suzuki, Akihito, Tsuyoshi Kondo, Kazuo Mihara, et al.. (2001). Association between Taq I A dopamine D 2 receptor polymorphism and therapeutic response to bromperidol: a preliminary report. European Archives of Psychiatry and Clinical Neuroscience. 251(2). 57–59. 21 indexed citations
16.
Yasui, Norio, Tsuyoshi Kondo, Hanako Furukori, et al.. (2000). Effects of repeated ingestion of grapefruit juice on the single and multiple oral-dose pharmacokinetics and pharmacodynamics of alprazolam. Psychopharmacology. 150(2). 185–190. 21 indexed citations
17.
Mihara, Kazuo, K. Otani, N. Yasui, et al.. (1999). No Pharmacokinetic but Pharmacodynamic Interactions Between Cisapride and Bromperidol or Haloperidol. Therapeutic Drug Monitoring. 21(3). 297–297. 2 indexed citations
18.
Yasui, Norio, Tsuyoshi Kondo, Koichi Otani, et al.. (1998). Effect of itraconazole on the single oral dose pharmacokinetics and pharmacodynamics of alprazolam. Psychopharmacology. 139(3). 269–273. 51 indexed citations
19.
Otani, K., M. Ishida, N. Yasui, et al.. (1997). Interaction between carbamazepine and bromperidol. European Journal of Clinical Pharmacology. 52(3). 219–222. 16 indexed citations
20.
Otani, K., Tsuyoshi Kondo, N. Yasui, et al.. (1997). Prolactin response to nemonapride, a new antipsychotic drug, in schizophrenic patients. Human Psychopharmacology Clinical and Experimental. 12(6). 591–594. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Taku Nakagami Breakdown of academic impact, for papers by Margaret T. Susce Breakdown of academic impact, for papers by Kelly L. Cozza Breakdown of academic impact, for papers by Roland Berecz Breakdown of academic impact, for papers by Maria I. Van Rompay Breakdown of academic impact, for papers by Takuro Sugai Breakdown of academic impact, for papers by Margaret A. Kirshner Breakdown of academic impact, for papers by Roos van Westrhenen Breakdown of academic impact, for papers by Timi Edeki Breakdown of academic impact, for papers by Pietro Gareri
Rankless by CCL
2026